Samuel Mackintosh
Concepts (498)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 23 | 2025 | 336 | 2.070 |
Why?
| | Proteome | 16 | 2025 | 177 | 1.970 |
Why?
| | Histones | 12 | 2025 | 318 | 1.420 |
Why?
| | Chromatin | 8 | 2025 | 145 | 0.810 |
Why?
| | Saccharomyces cerevisiae Proteins | 7 | 2019 | 131 | 0.670 |
Why?
| | DNA-Binding Proteins | 7 | 2021 | 423 | 0.630 |
Why?
| | Animals | 40 | 2025 | 13526 | 0.580 |
Why?
| | Viral Nonstructural Proteins | 4 | 2021 | 60 | 0.540 |
Why?
| | Phosphoproteins | 3 | 2025 | 117 | 0.510 |
Why?
| | Transcription Factors | 9 | 2025 | 571 | 0.500 |
Why?
| | Saccharomyces cerevisiae | 6 | 2019 | 166 | 0.470 |
Why?
| | Mice | 24 | 2025 | 5982 | 0.470 |
Why?
| | Staphylococcus aureus | 4 | 2025 | 313 | 0.470 |
Why?
| | Protein Interaction Mapping | 4 | 2020 | 38 | 0.460 |
Why?
| | DNA Replication | 2 | 2025 | 161 | 0.440 |
Why?
| | DNA Helicases | 3 | 2021 | 148 | 0.440 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2025 | 10 | 0.400 |
Why?
| | Bacterial Proteins | 4 | 2019 | 347 | 0.400 |
Why?
| | Ubiquitin-Protein Ligases | 3 | 2024 | 140 | 0.390 |
Why?
| | DNA | 4 | 2015 | 535 | 0.390 |
Why?
| | Septins | 2 | 2024 | 20 | 0.390 |
Why?
| | Cryptococcus neoformans | 2 | 2024 | 26 | 0.390 |
Why?
| | Interferon Type I | 2 | 2023 | 28 | 0.370 |
Why?
| | Protein Binding | 11 | 2025 | 670 | 0.370 |
Why?
| | Sepsis | 2 | 2025 | 240 | 0.370 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 136 | 0.370 |
Why?
| | Hepacivirus | 3 | 2010 | 105 | 0.370 |
Why?
| | Lysine | 3 | 2025 | 91 | 0.360 |
Why?
| | Fungal Proteins | 2 | 2024 | 110 | 0.360 |
Why?
| | G-Quadruplexes | 3 | 2019 | 77 | 0.350 |
Why?
| | Melanoma | 3 | 2024 | 277 | 0.340 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2021 | 36 | 0.340 |
Why?
| | Signal Transduction | 9 | 2025 | 1748 | 0.340 |
Why?
| | Blood Proteins | 2 | 2024 | 84 | 0.340 |
Why?
| | Protein Processing, Post-Translational | 6 | 2020 | 149 | 0.330 |
Why?
| | Virus Replication | 2 | 2015 | 149 | 0.320 |
Why?
| | Aging | 3 | 2024 | 714 | 0.320 |
Why?
| | Mass Spectrometry | 8 | 2021 | 294 | 0.320 |
Why?
| | Tandem Mass Spectrometry | 7 | 2020 | 254 | 0.320 |
Why?
| | Humans | 45 | 2025 | 53230 | 0.310 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2025 | 62 | 0.300 |
Why?
| | Proteolysis | 4 | 2023 | 105 | 0.290 |
Why?
| | HEK293 Cells | 7 | 2025 | 235 | 0.290 |
Why?
| | Blood Coagulation | 2 | 2025 | 65 | 0.280 |
Why?
| | Kidney | 2 | 2025 | 715 | 0.280 |
Why?
| | Antibodies, Monoclonal | 2 | 2025 | 477 | 0.270 |
Why?
| | Cell Cycle Checkpoints | 2 | 2019 | 32 | 0.270 |
Why?
| | Bone Resorption | 2 | 2022 | 304 | 0.260 |
Why?
| | Osteoclasts | 2 | 2022 | 428 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2020 | 205 | 0.250 |
Why?
| | Mice, Knockout | 7 | 2025 | 910 | 0.240 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2025 | 868 | 0.240 |
Why?
| | Bacillus anthracis | 1 | 2025 | 14 | 0.240 |
Why?
| | Anthrax | 1 | 2025 | 9 | 0.240 |
Why?
| | Brain Stem Neoplasms | 1 | 2025 | 7 | 0.230 |
Why?
| | Caenorhabditis elegans | 2 | 2016 | 131 | 0.230 |
Why?
| | Factor XI | 1 | 2025 | 4 | 0.230 |
Why?
| | Antigens, Bacterial | 1 | 2025 | 55 | 0.230 |
Why?
| | Gene Silencing | 2 | 2023 | 122 | 0.230 |
Why?
| | Bacterial Toxins | 1 | 2025 | 52 | 0.230 |
Why?
| | Blood Coagulation Disorders | 1 | 2025 | 41 | 0.230 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 1925 | 0.230 |
Why?
| | BRCA1 Protein | 1 | 2025 | 39 | 0.220 |
Why?
| | Co-Repressor Proteins | 2 | 2023 | 17 | 0.220 |
Why?
| | Homeodomain Proteins | 2 | 2025 | 81 | 0.220 |
Why?
| | Organ Preservation | 1 | 2025 | 33 | 0.220 |
Why?
| | Staphylococcal Infections | 2 | 2025 | 271 | 0.220 |
Why?
| | Glycine | 1 | 2025 | 75 | 0.220 |
Why?
| | Nuclear Proteins | 2 | 2016 | 250 | 0.220 |
Why?
| | Glioma | 1 | 2025 | 83 | 0.220 |
Why?
| | Heart Bypass, Right | 1 | 2024 | 13 | 0.220 |
Why?
| | Glucuronidase | 1 | 2024 | 47 | 0.210 |
Why?
| | Sirtuin 1 | 1 | 2024 | 29 | 0.210 |
Why?
| | Diastole | 1 | 2024 | 66 | 0.210 |
Why?
| | Arteriovenous Fistula | 1 | 2024 | 28 | 0.210 |
Why?
| | Phenylalanine | 1 | 2025 | 136 | 0.210 |
Why?
| | Pulmonary Veins | 1 | 2024 | 42 | 0.210 |
Why?
| | Chiroptera | 1 | 2023 | 4 | 0.210 |
Why?
| | Retroelements | 1 | 2023 | 13 | 0.210 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 262 | 0.210 |
Why?
| | Endogenous Retroviruses | 1 | 2023 | 7 | 0.200 |
Why?
| | Mediator Complex | 1 | 2023 | 4 | 0.200 |
Why?
| | Fontan Procedure | 1 | 2024 | 67 | 0.200 |
Why?
| | Disease Models, Animal | 6 | 2025 | 1517 | 0.200 |
Why?
| | Stress, Physiological | 1 | 2024 | 184 | 0.200 |
Why?
| | Membrane Proteins | 2 | 2016 | 333 | 0.200 |
Why?
| | Viruses | 1 | 2023 | 24 | 0.200 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2023 | 26 | 0.200 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 238 | 0.200 |
Why?
| | Methylation | 5 | 2025 | 127 | 0.200 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2016 | 301 | 0.200 |
Why?
| | Arteriovenous Malformations | 1 | 2024 | 75 | 0.200 |
Why?
| | Cell Cycle Proteins | 2 | 2021 | 170 | 0.200 |
Why?
| | Pulmonary Artery | 1 | 2024 | 142 | 0.190 |
Why?
| | Polycomb Repressive Complex 2 | 2 | 2021 | 48 | 0.190 |
Why?
| | Kidney Transplantation | 1 | 2025 | 203 | 0.190 |
Why?
| | Methionine | 1 | 2024 | 142 | 0.190 |
Why?
| | Peripheral Nerve Injuries | 1 | 2022 | 13 | 0.190 |
Why?
| | Trans-Activators | 2 | 2019 | 139 | 0.190 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2023 | 47 | 0.190 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 10 | 0.190 |
Why?
| | Cecum | 2 | 2021 | 62 | 0.190 |
Why?
| | Energy Metabolism | 1 | 2025 | 324 | 0.190 |
Why?
| | Epigenesis, Genetic | 4 | 2023 | 412 | 0.190 |
Why?
| | Receptors, Transferrin | 1 | 2022 | 16 | 0.190 |
Why?
| | Intellectual Disability | 1 | 2024 | 129 | 0.190 |
Why?
| | Ikaros Transcription Factor | 1 | 2022 | 5 | 0.190 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 37 | 0.180 |
Why?
| | Histone Acetyltransferases | 2 | 2014 | 26 | 0.180 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 1470 | 0.180 |
Why?
| | Cell Proliferation | 4 | 2021 | 1031 | 0.180 |
Why?
| | Mutation | 7 | 2020 | 1337 | 0.180 |
Why?
| | T-Lymphocytes | 2 | 2021 | 321 | 0.180 |
Why?
| | Liver Failure, Acute | 1 | 2022 | 57 | 0.180 |
Why?
| | DEAD-box RNA Helicases | 2 | 2019 | 34 | 0.180 |
Why?
| | Early Growth Response Protein 1 | 1 | 2021 | 34 | 0.180 |
Why?
| | Phosphofructokinase-1, Type C | 1 | 2021 | 3 | 0.170 |
Why?
| | YY1 Transcription Factor | 1 | 2021 | 7 | 0.170 |
Why?
| | Polycomb-Group Proteins | 1 | 2021 | 8 | 0.170 |
Why?
| | End Stage Liver Disease | 1 | 2022 | 52 | 0.170 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2021 | 24 | 0.170 |
Why?
| | Cell Line | 5 | 2023 | 1016 | 0.170 |
Why?
| | Cadherins | 2 | 2019 | 62 | 0.170 |
Why?
| | Iron | 1 | 2022 | 130 | 0.170 |
Why?
| | Neoplasms | 2 | 2021 | 1334 | 0.170 |
Why?
| | Uterine Artery | 1 | 2021 | 2 | 0.170 |
Why?
| | Lymphocyte Activation | 1 | 2021 | 163 | 0.170 |
Why?
| | Ozone | 1 | 2021 | 21 | 0.170 |
Why?
| | Apoptosis | 3 | 2021 | 1139 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2023 | 212 | 0.170 |
Why?
| | Transcriptional Activation | 4 | 2025 | 128 | 0.160 |
Why?
| | Vanadates | 1 | 2020 | 7 | 0.160 |
Why?
| | Phosphotyrosine | 1 | 2020 | 6 | 0.160 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 62 | 0.160 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 152 | 0.160 |
Why?
| | Multiple Myeloma | 3 | 2021 | 3082 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2020 | 112 | 0.160 |
Why?
| | Adenine | 2 | 2019 | 29 | 0.160 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 89 | 0.160 |
Why?
| | Infant Formula | 1 | 2021 | 154 | 0.160 |
Why?
| | HeLa Cells | 4 | 2025 | 243 | 0.160 |
Why?
| | Extracellular Matrix Proteins | 1 | 2020 | 69 | 0.150 |
Why?
| | Translocation, Genetic | 1 | 2021 | 266 | 0.150 |
Why?
| | DNA Damage | 2 | 2024 | 309 | 0.150 |
Why?
| | Liver Neoplasms | 1 | 2023 | 346 | 0.150 |
Why?
| | Alanine Transaminase | 1 | 2020 | 118 | 0.150 |
Why?
| | Molecular Chaperones | 1 | 2020 | 76 | 0.150 |
Why?
| | Collagen Type I | 1 | 2020 | 83 | 0.150 |
Why?
| | Poly(A)-Binding Proteins | 1 | 2019 | 6 | 0.150 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 815 | 0.150 |
Why?
| | Carrier Proteins | 1 | 2021 | 315 | 0.150 |
Why?
| | Repressor Proteins | 2 | 2019 | 149 | 0.150 |
Why?
| | Ribonucleoproteins | 1 | 2019 | 24 | 0.150 |
Why?
| | Protein Kinases | 1 | 2019 | 72 | 0.150 |
Why?
| | Lymphoma, Mantle-Cell | 1 | 2019 | 18 | 0.150 |
Why?
| | Ruminococcus | 1 | 2019 | 7 | 0.150 |
Why?
| | Starch | 1 | 2019 | 12 | 0.150 |
Why?
| | Xenopus Proteins | 1 | 2019 | 34 | 0.150 |
Why?
| | Arsenic | 1 | 2019 | 22 | 0.150 |
Why?
| | Integrin alpha Chains | 1 | 2019 | 12 | 0.150 |
Why?
| | Oxidative Phosphorylation | 1 | 2019 | 48 | 0.150 |
Why?
| | Virulence Factors | 1 | 2019 | 79 | 0.150 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 208 | 0.150 |
Why?
| | Melanoma, Experimental | 1 | 2019 | 34 | 0.140 |
Why?
| | Computational Biology | 1 | 2020 | 209 | 0.140 |
Why?
| | Antineoplastic Agents | 3 | 2022 | 1232 | 0.140 |
Why?
| | Oligonucleotides | 3 | 2008 | 77 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2022 | 202 | 0.140 |
Why?
| | Peptide Hydrolases | 1 | 2018 | 63 | 0.140 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 138 | 0.140 |
Why?
| | Osteomyelitis | 1 | 2019 | 134 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 350 | 0.140 |
Why?
| | Protein Biosynthesis | 2 | 2019 | 268 | 0.140 |
Why?
| | Software | 1 | 2020 | 280 | 0.140 |
Why?
| | Antigens, CD | 1 | 2019 | 217 | 0.130 |
Why?
| | Host-Pathogen Interactions | 2 | 2016 | 135 | 0.130 |
Why?
| | Kinetics | 4 | 2019 | 607 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 193 | 0.130 |
Why?
| | Female | 15 | 2025 | 28782 | 0.130 |
Why?
| | Breast Neoplasms | 2 | 2016 | 1222 | 0.130 |
Why?
| | Up-Regulation | 2 | 2016 | 456 | 0.130 |
Why?
| | Diet | 1 | 2021 | 610 | 0.130 |
Why?
| | CTLA-4 Antigen | 1 | 2017 | 32 | 0.130 |
Why?
| | Male | 12 | 2025 | 27435 | 0.130 |
Why?
| | Histone Code | 1 | 2017 | 32 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2017 | 46 | 0.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 20 | 0.130 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 48 | 0.130 |
Why?
| | Neoplasm Proteins | 2 | 2016 | 330 | 0.130 |
Why?
| | rab GTP-Binding Proteins | 1 | 2016 | 23 | 0.130 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.120 |
Why?
| | 3' Untranslated Regions | 1 | 2016 | 55 | 0.120 |
Why?
| | Mitochondria, Liver | 1 | 2017 | 69 | 0.120 |
Why?
| | RNA, Messenger | 2 | 2019 | 1133 | 0.120 |
Why?
| | Butadienes | 1 | 2017 | 49 | 0.120 |
Why?
| | Mitosis | 1 | 2016 | 86 | 0.120 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2016 | 17 | 0.120 |
Why?
| | Cytoplasmic Granules | 1 | 2016 | 17 | 0.120 |
Why?
| | Muscles | 1 | 2016 | 110 | 0.120 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 310 | 0.120 |
Why?
| | Whole-Body Irradiation | 1 | 2017 | 129 | 0.120 |
Why?
| | Vesicular Transport Proteins | 1 | 2016 | 33 | 0.120 |
Why?
| | Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.120 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2017 | 111 | 0.120 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2016 | 12 | 0.120 |
Why?
| | Lysosomes | 1 | 2016 | 68 | 0.120 |
Why?
| | Cytoplasm | 1 | 2016 | 93 | 0.120 |
Why?
| | Autoantigens | 1 | 2016 | 46 | 0.120 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 252 | 0.120 |
Why?
| | Tumor Burden | 1 | 2016 | 132 | 0.120 |
Why?
| | Recombinant Proteins | 3 | 2019 | 489 | 0.120 |
Why?
| | Viral Load | 1 | 2016 | 83 | 0.120 |
Why?
| | Human papillomavirus 16 | 1 | 2016 | 44 | 0.120 |
Why?
| | Carcinogens | 1 | 2017 | 194 | 0.120 |
Why?
| | Papio | 2 | 2025 | 25 | 0.120 |
Why?
| | Antigens, Viral | 1 | 2015 | 44 | 0.120 |
Why?
| | Chromatography, Liquid | 4 | 2020 | 245 | 0.120 |
Why?
| | Tumor Microenvironment | 3 | 2025 | 274 | 0.120 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 148 | 0.120 |
Why?
| | Rhadinovirus | 1 | 2015 | 22 | 0.120 |
Why?
| | Endoplasmic Reticulum | 1 | 2016 | 99 | 0.120 |
Why?
| | Cell Differentiation | 4 | 2021 | 681 | 0.110 |
Why?
| | Mice, SCID | 3 | 2021 | 180 | 0.110 |
Why?
| | Proteins | 1 | 2018 | 351 | 0.110 |
Why?
| | Rats | 4 | 2025 | 3162 | 0.110 |
Why?
| | Time Factors | 4 | 2025 | 2991 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 135 | 0.110 |
Why?
| | Acetylation | 3 | 2021 | 97 | 0.110 |
Why?
| | Collagen | 1 | 2016 | 215 | 0.110 |
Why?
| | Tetrahymena thermophila | 1 | 2014 | 3 | 0.110 |
Why?
| | Heterochromatin | 1 | 2014 | 4 | 0.110 |
Why?
| | Hippocampus | 1 | 2016 | 195 | 0.110 |
Why?
| | Protozoan Proteins | 1 | 2014 | 33 | 0.110 |
Why?
| | Genetic Loci | 1 | 2014 | 48 | 0.110 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2014 | 56 | 0.110 |
Why?
| | Cells, Cultured | 4 | 2020 | 1569 | 0.100 |
Why?
| | Papillomavirus Infections | 1 | 2016 | 177 | 0.100 |
Why?
| | RNA | 2 | 2023 | 173 | 0.100 |
Why?
| | Phosphorylation | 3 | 2023 | 533 | 0.100 |
Why?
| | Membrane Glycoproteins | 1 | 2014 | 238 | 0.100 |
Why?
| | Pancreatic Neoplasms | 1 | 2015 | 219 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2019 | 645 | 0.090 |
Why?
| | Alzheimer Disease | 1 | 2016 | 338 | 0.090 |
Why?
| | Gene Expression Profiling | 3 | 2023 | 1112 | 0.090 |
Why?
| | RNA Interference | 3 | 2016 | 181 | 0.090 |
Why?
| | DNA Methylation | 1 | 2016 | 592 | 0.090 |
Why?
| | Ligands | 3 | 2023 | 203 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2019 | 333 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2016 | 819 | 0.090 |
Why?
| | Animals, Newborn | 2 | 2023 | 357 | 0.090 |
Why?
| | Nevus, Pigmented | 1 | 2011 | 34 | 0.090 |
Why?
| | Jurkat Cells | 2 | 2021 | 29 | 0.080 |
Why?
| | Enhancer Elements, Genetic | 3 | 2021 | 60 | 0.080 |
Why?
| | Hypertension | 1 | 2016 | 554 | 0.080 |
Why?
| | Ovarian Neoplasms | 1 | 2014 | 459 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2016 | 501 | 0.080 |
Why?
| | Heat-Shock Response | 2 | 2020 | 29 | 0.080 |
Why?
| | Ubiquitination | 2 | 2024 | 58 | 0.080 |
Why?
| | Gene Deletion | 3 | 2016 | 279 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 3 | 2019 | 177 | 0.080 |
Why?
| | Movement | 1 | 2010 | 80 | 0.080 |
Why?
| | DNA, Viral | 1 | 2010 | 136 | 0.080 |
Why?
| | Bacteria | 2 | 2021 | 226 | 0.070 |
Why?
| | Albuminuria | 1 | 2009 | 49 | 0.070 |
Why?
| | Mice, Inbred NOD | 2 | 2021 | 90 | 0.070 |
Why?
| | Mitochondria | 2 | 2023 | 446 | 0.070 |
Why?
| | RNA Helicases | 1 | 2008 | 30 | 0.070 |
Why?
| | Virulence | 2 | 2019 | 163 | 0.070 |
Why?
| | Receptors, Cell Surface | 1 | 2009 | 109 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2016 | 1367 | 0.070 |
Why?
| | Acetaminophen | 2 | 2022 | 277 | 0.070 |
Why?
| | DNA Copy Number Variations | 2 | 2019 | 117 | 0.070 |
Why?
| | Biofilms | 2 | 2019 | 184 | 0.070 |
Why?
| | Cockayne Syndrome | 1 | 2006 | 3 | 0.060 |
Why?
| | Bloom Syndrome | 1 | 2006 | 4 | 0.060 |
Why?
| | Werner Syndrome | 1 | 2006 | 14 | 0.060 |
Why?
| | Disease Progression | 2 | 2020 | 880 | 0.060 |
Why?
| | Eukaryotic Cells | 1 | 2006 | 15 | 0.060 |
Why?
| | MCF-7 Cells | 2 | 2016 | 65 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2016 | 109 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 224 | 0.060 |
Why?
| | Skin Neoplasms | 1 | 2011 | 500 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 1544 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 214 | 0.060 |
Why?
| | Recombination, Genetic | 1 | 2006 | 95 | 0.060 |
Why?
| | Mutation, Missense | 2 | 2021 | 110 | 0.060 |
Why?
| | Cytokines | 2 | 2021 | 627 | 0.060 |
Why?
| | Spectrophotometry | 1 | 2005 | 26 | 0.060 |
Why?
| | Dimerization | 1 | 2005 | 50 | 0.060 |
Why?
| | Complement Activation | 1 | 2025 | 27 | 0.060 |
Why?
| | Spheroids, Cellular | 1 | 2025 | 27 | 0.060 |
Why?
| | Papio anubis | 1 | 2025 | 5 | 0.060 |
Why?
| | Origin Recognition Complex | 1 | 2025 | 6 | 0.060 |
Why?
| | Replication Origin | 1 | 2025 | 11 | 0.060 |
Why?
| | Crystallography, X-Ray | 1 | 2005 | 155 | 0.060 |
Why?
| | Adenosine Triphosphatases | 1 | 2005 | 92 | 0.060 |
Why?
| | Plasmids | 1 | 2005 | 164 | 0.060 |
Why?
| | Genome, Viral | 1 | 2005 | 78 | 0.060 |
Why?
| | Protein Conformation | 1 | 2005 | 174 | 0.060 |
Why?
| | Rats, Inbred Lew | 1 | 2025 | 48 | 0.060 |
Why?
| | Stromal Cells | 1 | 2025 | 77 | 0.060 |
Why?
| | Glucose Tolerance Test | 1 | 2025 | 61 | 0.060 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2019 | 49 | 0.060 |
Why?
| | Cell Membrane | 1 | 2005 | 233 | 0.050 |
Why?
| | Inflammation Mediators | 1 | 2025 | 115 | 0.050 |
Why?
| | Models, Molecular | 1 | 2005 | 352 | 0.050 |
Why?
| | Models, Statistical | 1 | 2005 | 229 | 0.050 |
Why?
| | Blotting, Western | 1 | 2005 | 587 | 0.050 |
Why?
| | Neutrophils | 1 | 2025 | 153 | 0.050 |
Why?
| | Jamaica | 1 | 2023 | 7 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 10 | 0.050 |
Why?
| | S-Adenosylmethionine | 1 | 2024 | 62 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2025 | 561 | 0.050 |
Why?
| | Hepatitis B virus | 1 | 2023 | 20 | 0.050 |
Why?
| | Genome | 1 | 2023 | 58 | 0.050 |
Why?
| | Adhesins, Bacterial | 1 | 2003 | 27 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 41 | 0.050 |
Why?
| | Microvessels | 1 | 2023 | 36 | 0.050 |
Why?
| | Homocysteine | 1 | 2024 | 127 | 0.050 |
Why?
| | Models, Biological | 1 | 2006 | 737 | 0.050 |
Why?
| | Sural Nerve | 1 | 2022 | 7 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2003 | 167 | 0.050 |
Why?
| | Histone Deacetylases | 1 | 2023 | 59 | 0.050 |
Why?
| | Nerve Regeneration | 1 | 2022 | 21 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2022 | 43 | 0.050 |
Why?
| | Reference Values | 2 | 2016 | 311 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2022 | 39 | 0.050 |
Why?
| | Hepatocytes | 1 | 2023 | 188 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2022 | 57 | 0.050 |
Why?
| | Antiviral Agents | 1 | 2023 | 179 | 0.050 |
Why?
| | Young Adult | 3 | 2016 | 4511 | 0.050 |
Why?
| | Substrate Specificity | 2 | 2015 | 197 | 0.050 |
Why?
| | Genomics | 1 | 2024 | 271 | 0.050 |
Why?
| | Protein Stability | 1 | 2021 | 45 | 0.040 |
Why?
| | Vero Cells | 1 | 2021 | 40 | 0.040 |
Why?
| | Influenza A virus | 1 | 2021 | 16 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2021 | 97 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 409 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 26 | 0.040 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2021 | 32 | 0.040 |
Why?
| | Promoter Regions, Genetic | 2 | 2019 | 465 | 0.040 |
Why?
| | Cryptococcosis | 1 | 2020 | 17 | 0.040 |
Why?
| | Models, Animal | 1 | 2021 | 233 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 76 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 40 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 121 | 0.040 |
Why?
| | Formaldehyde | 2 | 2011 | 51 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2020 | 59 | 0.040 |
Why?
| | Phosphopeptides | 1 | 2020 | 6 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 90 | 0.040 |
Why?
| | Adenosylhomocysteinase | 1 | 2020 | 8 | 0.040 |
Why?
| | Swine | 1 | 2021 | 440 | 0.040 |
Why?
| | Milk, Human | 1 | 2021 | 122 | 0.040 |
Why?
| | Ions | 1 | 2020 | 31 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2021 | 374 | 0.040 |
Why?
| | Alcohol Dehydrogenase | 1 | 2020 | 37 | 0.040 |
Why?
| | Workflow | 1 | 2020 | 53 | 0.040 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2020 | 24 | 0.040 |
Why?
| | Drug Discovery | 1 | 2020 | 94 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2021 | 187 | 0.040 |
Why?
| | Databases, Genetic | 1 | 2020 | 82 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 192 | 0.040 |
Why?
| | Poly(A)-Binding Protein I | 1 | 2019 | 6 | 0.040 |
Why?
| | Oogenesis | 1 | 2019 | 19 | 0.040 |
Why?
| | Polyadenylation | 1 | 2019 | 21 | 0.040 |
Why?
| | Base Sequence | 2 | 2015 | 620 | 0.040 |
Why?
| | Placenta | 1 | 2021 | 146 | 0.040 |
Why?
| | Arsenate Reductases | 1 | 2019 | 3 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2019 | 44 | 0.040 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 10 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2021 | 189 | 0.040 |
Why?
| | Binding Sites | 2 | 2014 | 373 | 0.040 |
Why?
| | Membrane Transport Proteins | 1 | 2019 | 46 | 0.040 |
Why?
| | Lung | 1 | 2022 | 481 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2022 | 1049 | 0.040 |
Why?
| | Oocytes | 1 | 2019 | 95 | 0.040 |
Why?
| | Piperidines | 1 | 2019 | 98 | 0.040 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 625 | 0.040 |
Why?
| | Heart Failure | 1 | 2024 | 531 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 133 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 441 | 0.030 |
Why?
| | Cell Cycle | 1 | 2019 | 237 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 211 | 0.030 |
Why?
| | Pyrazoles | 1 | 2019 | 123 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 145 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 205 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2018 | 90 | 0.030 |
Why?
| | Drug Overdose | 1 | 2020 | 170 | 0.030 |
Why?
| | Dexamethasone | 1 | 2020 | 429 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 83 | 0.030 |
Why?
| | Electron Transport Complex III | 1 | 2017 | 6 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 93 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2017 | 22 | 0.030 |
Why?
| | Macaca mulatta | 1 | 2017 | 94 | 0.030 |
Why?
| | CDC2 Protein Kinase | 1 | 2016 | 15 | 0.030 |
Why?
| | Retinoblastoma-Binding Protein 2 | 1 | 2016 | 6 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2017 | 24 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2017 | 21 | 0.030 |
Why?
| | Gamma Rays | 1 | 2017 | 48 | 0.030 |
Why?
| | Vinblastine | 1 | 2016 | 22 | 0.030 |
Why?
| | Ribonuclease III | 1 | 2016 | 15 | 0.030 |
Why?
| | Tubulin Modulators | 1 | 2016 | 28 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 2118 | 0.030 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2017 | 187 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2016 | 59 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2017 | 56 | 0.030 |
Why?
| | Intermediate Filament Proteins | 1 | 2016 | 12 | 0.030 |
Why?
| | Detergents | 1 | 2016 | 15 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2017 | 237 | 0.030 |
Why?
| | Endosomes | 1 | 2016 | 35 | 0.030 |
Why?
| | Thermodynamics | 1 | 2016 | 34 | 0.030 |
Why?
| | tau Proteins | 1 | 2016 | 25 | 0.030 |
Why?
| | 14-3-3 Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Codon, Nonsense | 1 | 2016 | 27 | 0.030 |
Why?
| | Thiolester Hydrolases | 1 | 2016 | 5 | 0.030 |
Why?
| | Cyclophilins | 1 | 2016 | 9 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2016 | 60 | 0.030 |
Why?
| | Cell Survival | 1 | 2018 | 600 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 367 | 0.030 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2016 | 17 | 0.030 |
Why?
| | X Chromosome | 1 | 2016 | 13 | 0.030 |
Why?
| | Vaccines, Subunit | 1 | 2016 | 15 | 0.030 |
Why?
| | DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 15 | 0.030 |
Why?
| | Hydroxylation | 1 | 2016 | 64 | 0.030 |
Why?
| | Solubility | 1 | 2016 | 83 | 0.030 |
Why?
| | Mammals | 1 | 2016 | 58 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2018 | 421 | 0.030 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2016 | 38 | 0.030 |
Why?
| | Endopeptidases | 1 | 2016 | 62 | 0.030 |
Why?
| | Centrifugation | 1 | 2015 | 12 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2016 | 121 | 0.030 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 46 | 0.030 |
Why?
| | DNA, Mitochondrial | 1 | 2017 | 116 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 2016 | 107 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 174 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2015 | 28 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 56 | 0.030 |
Why?
| | Adult | 3 | 2016 | 14534 | 0.030 |
Why?
| | Infant | 1 | 2024 | 3805 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 171 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 83 | 0.030 |
Why?
| | Myofibroblasts | 1 | 2016 | 50 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 122 | 0.030 |
Why?
| | Child, Preschool | 1 | 2024 | 4162 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2016 | 97 | 0.030 |
Why?
| | Lipids | 1 | 2016 | 163 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2016 | 116 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2015 | 60 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 359 | 0.030 |
Why?
| | Homeostasis | 1 | 2016 | 209 | 0.030 |
Why?
| | Computer Simulation | 1 | 2016 | 290 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 237 | 0.030 |
Why?
| | Brain | 1 | 2023 | 1350 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2016 | 81 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2016 | 180 | 0.030 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2014 | 14 | 0.030 |
Why?
| | Glycomics | 1 | 2014 | 9 | 0.030 |
Why?
| | Micronucleus, Germline | 1 | 2014 | 2 | 0.030 |
Why?
| | DNA, Protozoan | 1 | 2014 | 10 | 0.030 |
Why?
| | Genotype | 1 | 2016 | 563 | 0.030 |
Why?
| | Glycosylation | 1 | 2014 | 104 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2014 | 119 | 0.030 |
Why?
| | Meiosis | 1 | 2014 | 62 | 0.030 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2014 | 76 | 0.030 |
Why?
| | Liver | 1 | 2020 | 1150 | 0.030 |
Why?
| | Vaccination | 1 | 2016 | 310 | 0.030 |
Why?
| | Pregnancy | 1 | 2021 | 2608 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 563 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 759 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 803 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 1212 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 1136 | 0.020 |
Why?
| | Bone and Bones | 1 | 2016 | 501 | 0.020 |
Why?
| | Child | 1 | 2024 | 7379 | 0.020 |
Why?
| | gp100 Melanoma Antigen | 1 | 2011 | 8 | 0.020 |
Why?
| | Fixatives | 1 | 2011 | 12 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2011 | 35 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2011 | 39 | 0.020 |
Why?
| | Paraffin Embedding | 1 | 2011 | 52 | 0.020 |
Why?
| | Middle Aged | 2 | 2016 | 13419 | 0.020 |
Why?
| | Fluorescein | 1 | 2010 | 8 | 0.020 |
Why?
| | Streptavidin | 1 | 2010 | 17 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2010 | 44 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 45 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2010 | 94 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 88 | 0.020 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2009 | 9 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 3494 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 26 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2009 | 128 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2008 | 23 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2008 | 79 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 975 | 0.020 |
Why?
| | Diabetic Nephropathies | 1 | 2009 | 61 | 0.020 |
Why?
| | Blood Pressure | 1 | 2009 | 518 | 0.020 |
Why?
| | Consensus Sequence | 1 | 2003 | 22 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2003 | 71 | 0.010 |
Why?
| | Aged | 1 | 2016 | 10429 | 0.010 |
Why?
|
|
Mackintosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|